RANI logo

RANI Cash From Operations

Annual CFO

-$51.24 M
-$4.72 M-10.15%

December 31, 2023


Summary


Performance

RANI Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRANIcash flowmetrics:

Quarterly CFO

-$8.41 M
+$619.00 K+6.86%

September 30, 2024


Summary


Performance

RANI Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRANIcash flowmetrics:

TTM CFO

-$39.32 M
+$5.89 M+13.03%

September 30, 2024


Summary


Performance

RANI TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRANIcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

RANI Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.2%+6.9%+13.0%
3 y3 years-242.5%+6.9%+13.0%
5 y5 years-95.1%+6.9%+13.0%

RANI Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-58.9%at lowat high+42.5%-21.9%+26.4%
5 y5-year-242.5%at low-1355.2%+42.5%-542.3%+26.4%
alltimeall time-242.5%at low-1355.2%+42.5%-542.3%+26.4%

Rani Therapeutics Holdings Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$8.41 M(-6.9%)
-$39.32 M(-13.0%)
Jun 2024
-
-$9.03 M(-4.0%)
-$45.21 M(-6.7%)
Mar 2024
-
-$9.40 M(-24.7%)
-$48.48 M(-5.4%)
Dec 2023
-$51.24 M(+10.1%)
-$12.48 M(-12.8%)
-$51.24 M(-4.0%)
Sep 2023
-
-$14.30 M(+16.3%)
-$53.39 M(+4.1%)
Jun 2023
-
-$12.30 M(+1.2%)
-$51.28 M(+4.0%)
Mar 2023
-
-$12.15 M(-16.9%)
-$49.31 M(+6.0%)
Dec 2022
-$46.52 M
-$14.63 M(+19.9%)
-$46.52 M(+7.3%)
Sep 2022
-
-$12.20 M(+18.1%)
-$43.34 M(+2.6%)
Jun 2022
-
-$10.33 M(+10.3%)
-$42.26 M(+12.5%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$9.36 M(-18.2%)
-$37.56 M(+16.5%)
Dec 2021
-$32.24 M(+115.5%)
-$11.45 M(+3.0%)
-$32.24 M(+17.3%)
Sep 2021
-
-$11.12 M(+97.6%)
-$27.50 M(+75.1%)
Jun 2021
-
-$5.63 M(+39.0%)
-$15.71 M(+21.9%)
Mar 2021
-
-$4.05 M(-39.6%)
-$12.89 M(-13.9%)
Dec 2020
-$14.96 M(-43.0%)
-$6.70 M(-1100.0%)
-$14.96 M(+81.1%)
Sep 2020
-
$670.00 K(-123.9%)
-$8.26 M(-7.5%)
Jun 2020
-
-$2.81 M(-54.1%)
-$8.93 M(+45.9%)
Mar 2020
-
-$6.12 M
-$6.12 M
Dec 2019
-$26.27 M
-
-

FAQ

  • What is Rani Therapeutics Holdings annual cash flow from operations?
  • What is the all time high annual CFO for Rani Therapeutics Holdings?
  • What is Rani Therapeutics Holdings annual CFO year-on-year change?
  • What is Rani Therapeutics Holdings quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Rani Therapeutics Holdings?
  • What is Rani Therapeutics Holdings quarterly CFO year-on-year change?
  • What is Rani Therapeutics Holdings TTM cash flow from operations?
  • What is the all time high TTM CFO for Rani Therapeutics Holdings?
  • What is Rani Therapeutics Holdings TTM CFO year-on-year change?

What is Rani Therapeutics Holdings annual cash flow from operations?

The current annual CFO of RANI is -$51.24 M

What is the all time high annual CFO for Rani Therapeutics Holdings?

Rani Therapeutics Holdings all-time high annual cash flow from operations is -$14.96 M

What is Rani Therapeutics Holdings annual CFO year-on-year change?

Over the past year, RANI annual cash flow from operations has changed by -$4.72 M (-10.15%)

What is Rani Therapeutics Holdings quarterly cash flow from operations?

The current quarterly CFO of RANI is -$8.41 M

What is the all time high quarterly CFO for Rani Therapeutics Holdings?

Rani Therapeutics Holdings all-time high quarterly cash flow from operations is $670.00 K

What is Rani Therapeutics Holdings quarterly CFO year-on-year change?

Over the past year, RANI quarterly cash flow from operations has changed by +$619.00 K (+6.86%)

What is Rani Therapeutics Holdings TTM cash flow from operations?

The current TTM CFO of RANI is -$39.32 M

What is the all time high TTM CFO for Rani Therapeutics Holdings?

Rani Therapeutics Holdings all-time high TTM cash flow from operations is -$6.12 M

What is Rani Therapeutics Holdings TTM CFO year-on-year change?

Over the past year, RANI TTM cash flow from operations has changed by +$5.89 M (+13.03%)